Mohit Bansal analyst WELLS FARGO

Currently out of the existing stock ratings of Mohit Bansal, 200 are a BUY (63.9%), 111 are a HOLD (35.46%), 2 are a SELL (0.64%).

Mohit Bansal

Work Performance Price Targets & Ratings Chart

Analyst Mohit Bansal, currently employed at WELLS FARGO, carries an average stock price target met ratio of 64.1% that have a potential upside of 30.04% achieved within 239 days.

Mohit Bansal’s has documented 609 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on ABBV, AbbVie at 17-Aug-2026.

Wall Street Analyst Mohit Bansal

Analyst best performing recommendations are on RDUS (SCHNITZER STEEL INDUSTRIES).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) at 1/30/2025. The price target of $460 was fulfilled within 1 day with a profit of $21.6 (4.93%) receiving and performance score of 49.27.

Average potential price target upside

AGIO Agios Pharm ALXN Alexion Pharmaceuticals AMGN Amgen BIIB Biogen BMRN Biomarin Pharmaceutical CALA Calithera Biosciences CHRS Coherus BioSciences CTMX CytomX Therapeutics EPZM Epizyme FOLD Amicus Therapeutics GILD Gilead Sciences LLY Eli Lilly and Company MYOK MyoKardia MYOV Myovant Sciences Ltd PFE Pfizer RDUS Schnitzer Steel Industries REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals ABBV AbbVie BMY Bristol-Myers Squibb Company KRTX Karuna Therapeutics MRK Merck mpany SNSE Sensei Biotherapeutics STTK Shattuck Labs  NBIX Neurocrine Biosciences BOLD Audentes Therapeutics CERE Cerevel Therapeutics Holdings HALO Halozyme Therapeutics ONCE Spark Therapeutics KDNY Chinook Therapeutics IRWD Ironwood Pharmaceuticals TVTX Travere Therapeutics JAZZ Jazz Pharmaceuticals PLC XENE Xenon Pharmaceuticals BNTX BioNTech SE FBRX Forte Biosciences IDYA Ideaya Biosciences MIST Milestone Pharmaceuticals CAL Caleres MLYS Mineralys Therapeutics, Common Stock

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 01-Dec-2022

$34

$0.68 (2.04%)

$31

Buy Since 05-Mar-2026

$52

$18.68 (56.06%)

$46

Buy Since 05-Jan-2024

$39

$5.68 (17.05%)

$41

Buy Since 24-Feb-2025

$55

$21.68 (65.07%)

$52

Buy Since 04-Dec-2021

$40

$6.68 (20.05%)

$41

Show more analysts

Please expand the browser size to see the chart

Which stock is Mohit Bansal is most bullish on?

Potential upside of $155.39 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Mohit Bansal is most reserved on?

Potential downside of -$44.19 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Mohit Bansal?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?